An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease - Sandborn,W.J.; Hanauer,S.; Loftus,E.V. (Am J Gastroenterol, 2004)